Fertility Clinics in the United States

The United States operates the world's largest and most technologically advanced fertility market, performing more than 400,000 assisted reproductive technology (ART) cycles annually. Unlike most countries, there is no federal regulatory body governing IVF — oversight falls to individual states, professional societies such as ASRM (American Society for Reproductive Medicine), and voluntary accreditation through SART (Society for Assisted Reproductive Technology). This results in a highly competitive, innovation-driven landscape where cutting-edge techniques including preimplantation genetic testing (PGT-A/PGT-M), time-lapse embryo monitoring, artificial intelligence embryo grading, and mitochondrial assessment are widely available. National average live birth rates per transfer hover between 35–45% depending on patient age and clinic, with top programs regularly exceeding 50% for patients under 35.

Compensated egg donation and gestational surrogacy are broadly legal across most US states, making the country one of the few destinations where all parties — intended parents, donors, and surrogates — can enter into legally enforceable contracts. Egg donor compensation typically ranges from $8,000–$15,000+ per cycle; gestational surrogacy total costs (agency, legal, medical, and compensation) commonly run $100,000–$200,000 or more. Insurance coverage for fertility treatments varies dramatically: approximately 20 states have some form of fertility insurance mandate, with Illinois, New York, New Jersey, and Massachusetts offering the strongest protections. The US remains the top destination for international patients seeking surrogacy, LGBTQ+ family-building, or access to the broadest range of donor genetic profiles. Major hub cities include New York, Los Angeles, San Francisco, Boston, Chicago, Denver, Houston, and Seattle.